Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients
Status:
Completed
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
This study compared long term outcome of stage IIIB/C and IV breast cancer patients treated
with neoadjuvant hormonal therapy (NAHT) and those treated with neoadjuvant chemotherapy
(NACT)